BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keyhanmehr N, Motedayyen H, Eskandari N. The Effects of Silymarin and Cyclosporine A on the Proliferation and Cytokine Production of Regulatory T Cells. Immunological Investigations 2019;48:533-48. [DOI: 10.1080/08820139.2019.1571506] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Sami R, Fathi F, Eskandari N, Ahmadi M, ArefNezhad R, Motedayyen H. Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome? Cytokine 2021;140:155439. [PMID: 33524886 DOI: 10.1016/j.cyto.2021.155439] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Long Y, Zhao X, Xia C, Liu X, Fan C, Liu C. Infection of Epstein-Barr Virus is Associated with the Decrease of Helios+FoxP3+Regulatory T Cells in Active Ulcerative Colitis Patients. Immunol Invest 2021;50:23-36. [PMID: 32046542 DOI: 10.1080/08820139.2020.1723021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li H, Zhu XX, Xiang JB, Jian L. Buserelin Inhibits the Immunosuppressive Activity of Regulatory T Cells through the Protein Kinase A Signaling in a Central Precocious Puberty Model. Immunol Invest 2021;:1-15. [PMID: 33586576 DOI: 10.1080/08820139.2021.1885437] [Reference Citation Analysis]
4 Fathi F, Sadeghi E, Lotfi N, Hafezi H, Ahmadi M, Mozafarpoor S, Motedayyen H. Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus. Int J Immunogenet 2020;47:57-64. [PMID: 31565862 DOI: 10.1111/iji.12456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
5 Fathi F, Saidi RF, Banafshe HR, Arbabi M, Lotfinia M, Motedayyen H. Changes in immune profile affect disease progression in hepatocellular carcinoma. Int J Immunopathol Pharmacol 2022;36:3946320221078476. [PMID: 35226515 DOI: 10.1177/03946320221078476] [Reference Citation Analysis]